Detalles de la búsqueda
1.
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
Ann Intern Med
; 175(9): 1221-1229, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35939812
2.
Efficacy and safety of a two-drug direct-acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6.
J Viral Hepat
; 26(9): 1127-1138, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31108015
3.
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.
Ann Intern Med
; 165(9): 625-634, 2016 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27537841
4.
Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom.
Clin Infect Dis
; 73(5): 935-936, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34492702
5.
Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.
J Hepatol
; 65(6): 1112-1119, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27542322
6.
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in Japanese healthy adults: A Phase I study.
Hum Vaccin Immunother
; 19(2): 2228162, 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37389808
7.
Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infection.
J Addict Dis
; 41(3): 213-224, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-35920743
8.
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial.
Lancet Infect Dis
; 23(2): 233-246, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36116461
9.
Safety and Immunogenicity of V114, a 15-valent Pneumococcal Conjugate Vaccine, Compared with 13-valent Pneumococcal Conjugate Vaccine in Japanese Adults Aged ≥65 Years: Subgroup Analysis of a Randomized Phase III Trial (PNEU-AGE).
Jpn J Infect Dis
; 75(6): 575-582, 2022 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35908869
10.
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE).
Vaccine
; 40(1): 162-172, 2022 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34507861
11.
The Immunogenicity and Safety Profile for KM-248, a Combined Measles, Mumps, and Rubella Vaccine, and Its Noninferiority to the Measles Vaccine in Healthy Japanese Children: a Phase 3 Randomized Multicenter Single-Blind Clinical Trial.
Jpn J Infect Dis
; 74(5): 429-436, 2021 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33518626
12.
Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults.
Hum Vaccin Immunother
; 17(11): 4177-4182, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34473594
13.
Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents.
Hum Vaccin Immunother
; 17(11): 4183-4189, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34702124
14.
A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II).
Hum Vaccin Immunother
; 16(11): 2634-2640, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32429738
15.
A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Pediatr Infect Dis J
; 39(8): 763-770, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32639460
16.
Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study.
Clin Transl Gastroenterol
; 10(4): e00007, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30939489
17.
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study.
J Clin Oncol
; 37(4): 296-304, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30562130
18.
Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir.
Patient Prefer Adherence
; 12: 2631-2638, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30587935
19.
The safety and efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 1b infection.
J Gastroenterol
; 53(5): 679-688, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29344726
20.
Low-cost inorganic solar cells: from ink to printed device.
Chem Rev
; 110(11): 6571-94, 2010 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20973478